Correlation Between Kiniksa Pharmaceuticals and Coherus BioSciences
Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Coherus BioSciences, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Coherus BioSciences.
Diversification Opportunities for Kiniksa Pharmaceuticals and Coherus BioSciences
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kiniksa and Coherus is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Coherus BioSciences go up and down completely randomly.
Pair Corralation between Kiniksa Pharmaceuticals and Coherus BioSciences
Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 0.47 times more return on investment than Coherus BioSciences. However, Kiniksa Pharmaceuticals is 2.13 times less risky than Coherus BioSciences. It trades about 0.03 of its potential returns per unit of risk. Coherus BioSciences is currently generating about -0.01 per unit of risk. If you would invest 1,812 in Kiniksa Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 154.00 from holding Kiniksa Pharmaceuticals or generate 8.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiniksa Pharmaceuticals vs. Coherus BioSciences
Performance |
| Timeline |
| Kiniksa Pharmaceuticals |
| Coherus BioSciences |
Kiniksa Pharmaceuticals and Coherus BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiniksa Pharmaceuticals and Coherus BioSciences
The main advantage of trading using opposite Kiniksa Pharmaceuticals and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |